XNAS · Healthcare · Medical Devices
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Q1 2026 | — | -5.89 | — | $0 | — | +1.01% | +0.78% | — |
| 2026-03-27 | Q4 2025 | -0.28 | -6.05 | -2060.71% | $0 | ❌ Miss | -1.05% | -0.57% | +12.56% |
| 2025-10-31 |
| Q3 2025 |
| -0.30 |
| -0.23 |
| +23.33% |
| $0 |
| ✅ Beat |
| — |
| — |
| — |
| 2025-02-28 | Q4 2024 | -0.35 | -0.30 | +14.29% | $0 | ✅ Beat | -5.97% | -3.46% | -17.30% |
| 2024-10-31 | Q3 2024 | -0.33 | -0.35 | -6.06% | $0 | ❌ Miss | -0.59% | +4.15% | -5.93% |
| 2024-07-31 | Q2 2024 | -0.36 | -0.31 | +13.89% | $0 | ✅ Beat | -0.93% | -7.62% | -2.23% |
| 2024-05-08 | Q1 2024 | -0.40 | -0.31 | +22.50% | $0 | ✅ Beat | -2.55% | -1.96% | -8.24% |
| 2024-02-29 | Q4 2023 | -0.46 | -0.32 | +30.43% | $0 | ✅ Beat | — | — | — |
Showing last 8 quarters.